News

AMR Policy Accelerator Publishes Rapid Scoping Review on The Effects of the COVID-19 Pandemic on the Three Core Drivers of AMR

February 6, 2023

Our AMR Policy Accelerator team conducted a rapid scoping review to explore how several factors have impacted the emergence, transmission and burden of Antimicrobial Resistance (AMR) during the COVID-19 pandemic. The living evidence synthesis looked at: antimicrobial use (AMU), infection prevention and health system changes. This living evidence synthesis was commissioned by Health Canada and Public Health Agency of Canada and was funded by Covid-End.

While more research is needed to fully understand the impact, initial findings show:

  • AMR trends varied across countries In many countries

  • AMU increased in hospitals but decreased in the community likely due to COVID countermeasures that reduced the spread of infections

Key areas were identified for further discussion & research:

  • improving AMR surveillance

  • identifying and addressing the potential inequitable effects of AMR

  • addressing gaps in the global evidence base

Read the full report here: https://t.co/ixm5TEBIAK

Previous

January 12, 2023

Dr. Susan Rogers Van Katwyk Speaks to CTV on the Impact of Antimicrobial Resistance

Next

February 8, 2023

GSL Study featured in York University's Impact Report 2021-22: Special Issue on Research & Teaching